PODD vs. ARWR
Compare and contrast key facts about Insulet Corporation (PODD) and Arrowhead Pharmaceuticals, Inc. (ARWR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PODD or ARWR.
Key characteristics
| PODD | ARWR | |
|---|---|---|
| YTD Return | -19.61% | -20.13% |
| 1Y Return | -45.87% | -38.98% |
| 3Y Return (Ann) | -13.78% | -28.46% |
| 5Y Return (Ann) | 12.54% | 6.16% |
| 10Y Return (Ann) | 16.85% | 9.13% |
| Sharpe Ratio | -1.08 | -0.65 |
| Daily Std Dev | 42.14% | 60.65% |
| Max Drawdown | -90.28% | -99.96% |
| Current Drawdown | -47.18% | -99.16% |
Fundamentals
| PODD | ARWR | |
|---|---|---|
| Market Cap | $12.21B | $3.03B |
| EPS | $2.95 | -$2.77 |
| PEG Ratio | 3.15 | -1.32 |
| Revenue (TTM) | $1.70B | $181.74M |
| Gross Profit (TTM) | $805.60M | $240.74M |
| EBITDA (TTM) | $308.60M | -$285.35M |
Correlation
The correlation between PODD and ARWR is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PODD vs. ARWR - Performance Comparison
The year-to-date returns for both stocks are quite close, with PODD having a -19.61% return and ARWR slightly lower at -20.13%. Over the past 10 years, PODD has outperformed ARWR with an annualized return of 16.85%, while ARWR has yielded a comparatively lower 9.13% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PODD vs. ARWR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PODD vs. ARWR - Dividend Comparison
Neither PODD nor ARWR has paid dividends to shareholders.
Drawdowns
PODD vs. ARWR - Drawdown Comparison
The maximum PODD drawdown since its inception was -90.28%, smaller than the maximum ARWR drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for PODD and ARWR. For additional features, visit the drawdowns tool.
Volatility
PODD vs. ARWR - Volatility Comparison
The current volatility for Insulet Corporation (PODD) is 8.86%, while Arrowhead Pharmaceuticals, Inc. (ARWR) has a volatility of 14.83%. This indicates that PODD experiences smaller price fluctuations and is considered to be less risky than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PODD vs. ARWR - Financials Comparison
This section allows you to compare key financial metrics between Insulet Corporation and Arrowhead Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities